Nifty
Sensex
:
:
18306.65
61490.05
38.25 (0.21%)
139.79 (0.23%)

Pharmaceuticals & Drugs - Global

Rating :
39/99

BSE: 532531 | NSE: STAR

538.15
26-Oct-2021
  • Open
  • High
  • Low
  • Previous Close
  •  535.00
  •  543.75
  •  530.70
  •  531.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  662241
  •  3560.51
  •  999.00
  •  528.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,832.72
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,756.34
  • 0.46%
  • 1.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.60%
  • 0.00%
  • 17.89%
  • FII
  • DII
  • Others
  • 24.96%
  • 19.16%
  • 8.39%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -2.82
  • 2.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 3.93
  • 16.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.72
  • -0.37

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.43
  • 21.81
  • 11.65

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.99
  • 2.20
  • 1.89

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.84
  • 13.65
  • 12.74

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
688.37
781.80
-11.95%
908.49
618.64
46.85%
832.02
732.44
13.60%
793.56
715.09
10.97%
Expenses
743.72
630.79
17.90%
751.26
553.61
35.70%
672.62
551.59
21.94%
636.35
568.50
11.93%
EBITDA
-55.35
151.01
-
157.24
65.04
141.76%
159.41
180.84
-11.85%
157.21
146.59
7.24%
EBIDTM
-8.04%
19.32%
17.31%
10.51%
19.16%
24.69%
19.81%
20.50%
Other Income
18.65
16.20
15.12%
13.05
17.65
-26.06%
14.40
13.65
5.49%
17.75
14.07
26.15%
Interest
41.45
36.91
12.30%
41.61
40.33
3.17%
34.68
39.63
-12.49%
36.87
40.42
-8.78%
Depreciation
54.88
49.13
11.70%
51.86
45.34
14.38%
52.51
43.47
20.80%
52.79
42.00
25.69%
PBT
-224.58
126.08
-
75.89
-173.08
-
72.85
127.02
-42.65%
98.44
161.68
-39.11%
Tax
-35.54
3.28
-
11.49
-10.47
-
10.77
11.30
-4.69%
6.10
7.38
-17.34%
PAT
-189.04
122.80
-
64.40
-162.61
-
62.07
115.72
-46.36%
92.34
154.30
-40.16%
PATM
-27.46%
15.71%
7.09%
-26.28%
7.46%
15.80%
11.64%
21.58%
EPS
-22.87
11.56
-
5.14
-22.77
-
4.22
10.49
-59.77%
9.03
15.94
-43.35%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Net Sales
3,222.44
3,315.87
2,981.12
3,108.33
3,344.37
3,826.22
2,862.19
1,195.85
1,340.96
961.76
2,550.04
Net Sales Growth
13.15%
11.23%
-4.09%
-7.06%
-12.59%
33.68%
139.34%
-10.82%
39.43%
-62.28%
 
Cost Of Goods Sold
1,379.61
1,332.79
1,122.48
1,085.20
1,378.84
1,281.17
1,502.29
560.49
714.67
491.82
1,264.39
Gross Profit
1,842.83
1,983.08
1,858.64
2,023.14
1,965.53
2,545.05
1,359.90
635.37
626.30
469.94
1,285.66
GP Margin
57.19%
59.81%
62.35%
65.09%
58.77%
66.52%
47.51%
53.13%
46.71%
48.86%
50.42%
Total Expenditure
2,803.95
2,689.06
2,470.90
2,811.65
3,108.66
3,309.30
2,481.62
967.00
1,117.54
861.18
2,059.36
Power & Fuel Cost
-
64.58
64.49
54.39
51.33
33.87
77.18
16.02
18.56
12.84
54.24
% Of Sales
-
1.95%
2.16%
1.75%
1.53%
0.89%
2.70%
1.34%
1.38%
1.34%
2.13%
Employee Cost
-
550.15
442.56
329.44
434.05
419.16
357.69
172.06
157.18
120.30
302.74
% Of Sales
-
16.59%
14.85%
10.60%
12.98%
10.95%
12.50%
14.39%
11.72%
12.51%
11.87%
Manufacturing Exp.
-
237.94
210.79
150.98
115.97
137.47
119.23
41.37
35.76
44.43
89.60
% Of Sales
-
7.18%
7.07%
4.86%
3.47%
3.59%
4.17%
3.46%
2.67%
4.62%
3.51%
General & Admin Exp.
-
191.73
191.89
150.10
194.38
172.63
198.71
86.25
66.37
58.16
182.12
% Of Sales
-
5.78%
6.44%
4.83%
5.81%
4.51%
6.94%
7.21%
4.95%
6.05%
7.14%
Selling & Distn. Exp.
-
223.22
137.07
111.22
208.85
161.12
129.57
61.37
66.67
39.94
116.07
% Of Sales
-
6.73%
4.60%
3.58%
6.24%
4.21%
4.53%
5.13%
4.97%
4.15%
4.55%
Miscellaneous Exp.
-
88.65
301.61
930.33
725.25
1,103.88
96.95
29.44
58.33
93.69
116.07
% Of Sales
-
2.67%
10.12%
29.93%
21.69%
28.85%
3.39%
2.46%
4.35%
9.74%
1.97%
EBITDA
418.51
626.81
510.22
296.68
235.71
516.92
380.57
228.85
223.42
100.58
490.68
EBITDA Margin
12.99%
18.90%
17.12%
9.54%
7.05%
13.51%
13.30%
19.14%
16.66%
10.46%
19.24%
Other Income
63.85
73.39
66.70
322.90
920.64
398.08
102.37
38.57
60.23
34.20
31.67
Interest
154.61
150.06
155.72
79.29
196.24
183.10
168.17
47.44
108.88
79.45
194.83
Depreciation
212.04
206.29
187.79
171.85
193.93
198.69
131.25
64.03
56.48
30.86
104.30
PBT
22.60
343.85
233.42
368.44
766.17
533.20
183.50
155.95
118.30
24.48
223.22
Tax
-7.18
31.65
17.91
14.49
21.41
51.19
42.45
147.60
40.86
11.15
38.68
Tax Rate
-31.77%
8.17%
11.50%
3.71%
2.96%
10.30%
29.87%
99.35%
44.53%
1.54%
14.18%
PAT
29.77
366.26
143.62
370.31
681.31
399.38
113.21
1.57
50.89
712.39
224.48
PAT before Minority Interest
42.13
355.55
137.82
375.57
701.18
445.58
99.68
0.98
50.89
713.44
234.01
Minority Interest
12.36
10.71
5.80
-5.26
-19.87
-46.20
13.53
0.59
0.00
-1.05
-9.53
PAT Margin
0.92%
11.05%
4.82%
11.91%
20.37%
10.44%
3.96%
0.13%
3.80%
74.07%
8.80%
PAT Growth
-87.07%
155.02%
-61.22%
-45.65%
70.59%
252.78%
7,110.83%
-96.91%
-92.86%
217.35%
 
EPS
3.32
40.79
15.99
41.24
75.87
44.47
12.61
0.17
5.67
79.33
25.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Shareholder's Funds
2,776.66
2,527.42
2,648.70
2,463.66
2,748.82
2,657.87
1,144.92
1,006.83
2,026.24
1,371.48
Share Capital
89.68
89.56
89.55
89.50
89.42
89.35
59.62
59.57
58.80
58.38
Total Reserves
2,682.26
2,432.13
2,551.59
2,365.10
2,650.55
2,562.75
1,084.50
947.06
1,963.94
1,310.34
Non-Current Liabilities
1,264.45
813.65
2,342.88
2,067.29
2,048.67
2,760.03
285.79
306.42
900.59
1,132.57
Secured Loans
873.43
601.79
1,806.45
1,551.09
1,622.87
2,614.88
250.23
274.29
731.15
1,054.31
Unsecured Loans
9.15
2.12
0.06
0.23
14.84
12.13
17.16
1.24
0.00
0.00
Long Term Provisions
246.50
63.95
52.24
16.55
25.19
14.45
6.02
16.56
57.25
66.19
Current Liabilities
2,738.35
2,544.86
2,662.24
1,899.30
3,103.87
1,891.98
1,019.94
707.37
1,797.29
2,791.73
Trade Payables
1,178.62
797.75
888.99
712.07
774.09
775.40
234.41
262.31
463.08
585.04
Other Current Liabilities
376.58
354.49
248.12
129.98
819.08
347.93
502.47
127.27
651.65
1,369.80
Short Term Borrowings
1,023.84
1,228.78
1,339.02
944.39
1,393.96
700.48
203.03
224.56
599.89
684.65
Short Term Provisions
159.31
163.84
186.11
112.86
116.73
68.19
80.03
93.23
82.66
152.24
Total Liabilities
6,816.80
5,953.17
7,806.77
6,584.90
8,034.86
7,360.09
2,469.36
2,096.29
4,795.97
5,342.24
Net Block
2,151.13
2,025.85
3,570.13
2,903.00
2,909.03
2,678.68
701.36
554.53
3,016.72
3,187.64
Gross Block
2,841.28
2,534.38
4,049.05
3,229.03
3,186.12
2,825.43
1,080.55
907.33
3,514.29
3,644.82
Accumulated Depreciation
690.15
508.53
478.92
326.03
277.09
146.75
379.19
352.80
497.57
457.19
Non Current Assets
3,999.57
3,581.05
4,758.05
4,101.31
4,243.05
3,845.20
1,039.91
787.65
3,383.87
3,711.33
Capital Work in Progress
447.37
412.95
453.03
620.29
780.18
814.88
171.17
99.47
241.44
285.03
Non Current Investment
666.23
503.24
494.34
350.08
315.66
127.19
68.76
41.80
0.00
0.00
Long Term Loans & Adv.
185.80
210.82
223.69
197.22
222.56
201.83
96.72
90.40
118.75
229.99
Other Non Current Assets
549.04
428.19
16.86
30.72
15.62
22.62
1.91
1.45
6.96
8.67
Current Assets
2,817.23
2,372.11
3,048.72
2,483.59
3,791.82
3,514.89
1,429.44
1,308.63
1,410.94
1,625.27
Current Investments
99.41
118.97
284.75
311.48
1,279.54
1,213.76
561.29
401.24
0.06
0.00
Inventories
1,200.70
782.54
874.16
552.02
732.80
613.14
207.68
175.99
442.33
479.93
Sundry Debtors
1,106.86
931.69
987.18
882.18
995.91
1,032.97
389.96
364.00
483.23
538.44
Cash & Bank
179.76
237.10
516.65
303.33
329.48
311.59
146.88
231.15
165.74
259.73
Other Current Assets
230.49
83.57
136.87
138.84
454.09
343.44
123.64
136.26
319.58
347.17
Short Term Loans & Adv.
132.27
218.24
249.11
295.75
244.39
97.54
54.46
79.06
44.38
91.79
Net Current Assets
78.89
-172.75
386.48
584.29
687.95
1,622.91
409.50
601.26
-386.35
-1,166.46
Total Assets
6,816.80
5,953.16
7,806.77
6,584.90
8,034.87
7,360.09
2,469.35
2,096.28
4,795.98
5,342.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Cash From Operating Activity
481.44
204.79
60.05
187.07
288.14
73.25
83.40
-271.68
134.26
457.10
PBT
289.38
48.51
344.37
705.80
497.14
146.44
992.01
2,889.87
949.49
272.69
Adjustment
363.31
527.49
94.59
-274.51
190.92
345.56
-756.73
-2,775.01
-415.93
113.84
Changes in Working Capital
-328.05
-326.23
-323.14
-190.66
-341.30
-341.71
-95.91
-260.68
-310.56
128.87
Cash after chg. in Working capital
324.64
249.76
115.82
240.63
346.76
150.29
139.37
-145.81
223.00
515.40
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
156.80
-44.98
-55.76
-53.56
-58.62
-77.04
-55.97
-125.87
-88.75
-58.30
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-520.82
1,306.16
-148.49
582.59
-686.69
-2,224.83
51.87
4,077.09
806.54
-656.47
Net Fixed Assets
-86.75
-167.06
-48.49
677.20
-236.66
-535.93
-66.57
-119.10
-38.27
-18.46
Net Investments
-219.57
-17.15
-383.09
747.64
-143.27
-1,478.58
78.09
248.81
-508.54
77.70
Others
-214.50
1,490.37
283.09
-842.25
-306.76
-210.32
40.35
3,947.38
1,353.35
-715.71
Cash from Financing Activity
-15.80
-1,709.45
194.27
-1,015.69
338.21
2,943.94
-421.25
-3,318.53
-990.03
89.36
Net Cash Inflow / Outflow
-55.18
-198.50
105.83
-246.03
-60.33
792.35
-285.98
486.88
-49.23
-110.01
Opening Cash & Equivalents
182.23
365.89
256.16
515.08
1,110.74
298.91
586.00
132.02
211.93
325.17
Closing Cash & Equivalent
125.83
182.23
365.89
256.16
515.08
1,110.74
298.42
586.00
132.02
212.27

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Book Value (Rs.)
309.09
281.55
294.94
274.26
306.41
296.83
191.91
168.99
343.78
233.49
ROA
5.57%
2.00%
5.22%
9.59%
5.79%
2.03%
0.04%
1.48%
14.07%
4.76%
ROE
13.43%
5.34%
14.74%
27.00%
16.53%
5.25%
0.09%
3.36%
42.16%
17.77%
ROCE
11.47%
6.01%
8.65%
16.07%
10.75%
7.54%
10.92%
7.76%
21.08%
12.82%
Fixed Asset Turnover
2.04
1.50
1.17
1.04
1.27
1.47
1.21
0.61
0.27
0.82
Receivable days
67.97
70.88
79.95
102.49
96.77
90.73
114.71
114.80
193.43
65.68
Inventory Days
66.13
61.20
61.00
70.11
64.20
52.34
58.37
83.78
174.61
56.40
Payable days
119.92
138.58
146.59
116.23
117.33
75.51
76.81
112.69
253.28
92.58
Cash Conversion Cycle
14.18
-6.50
-5.64
56.37
43.64
67.55
96.27
85.89
114.76
29.50
Total Debt/Equity
0.76
0.78
1.22
1.03
1.35
1.34
0.78
0.54
0.79
1.94
Interest Cover
3.58
2.00
5.92
4.68
3.71
1.85
4.13
1.84
10.12
2.40

News Update:


  • Strides Pharma Science reports consolidated net loss of Rs 205 crore in Q1
    7th Aug 2021, 11:15 AM

    Total consolidated income of the company decreased by by 11.61% at Rs 701.90 crore for Q1FY22

    Read More
  • Strides Pharma Science’s arms ink definitive agreement with subsidiaries of Endo
    6th Aug 2021, 09:57 AM

    The cumulative addressable market for the acquired portfolio is $4.7 billion (IQVIA MAT May 2021)

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.